TRCT
BRNS

Tower Research Capital (TRC)’s Barinthus Biotherapeutics BRNS Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
2023
Q3 		$309 Sell
2023
Q2 		$251 Buy